Effective dose: how should it be applied to medical exposures?

被引:284
作者
Martin, C. J. [1 ]
机构
[1] Gartnavel Royal Hosp, Dept Clin Phys & Bioengn, Glasgow G12 0XH, Lanark, Scotland
关键词
D O I
10.1259/bjr/25922439
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The effective dose (E) was created to provide a dose quantity that was related to the probability of health detriment due to stochastic effects from exposure to low doses of ionizing radiation. E is derived from the weighted sum of doses to tissues that are known to be sensitive to radiation and so can only be derived by calculation. The tissue weighting factors are derived from the extrapolation of epidemiological evidence. E was intended for use in radiation protection, but has found wide application in evaluation of doses for medical exposures involving only parts of the body. More reliance is often placed on E values and risk estimates based on E than the evidence on which it is based can justify. In this paper, the uncertainties in the estimated values of E for a reference patient and the associated risk coefficients are reviewed in order to provide an indication of how much reliance can be placed on E as an indicator of risk for patients. The relative uncertainty in estimated values of E for medical exposures for a reference patient is seen to be about +/- 40%. The estimated risk of cancer may be a factor of three higher or lower when applied to a reference patient, and will be more variable when applied to an individual. A set of recommendations relating to the use of E and description of risk for medical exposures is proposed. (C) 2007 The British Institute of Radiology.
引用
收藏
页码:639 / 647
页数:9
相关论文
共 50 条
[1]  
[Anonymous], 1997, 126 NAT COUNC RAD PR
[2]   RADIATION-DOSE AND SECOND CANCER RISK IN PATIENTS TREATED FOR CANCER OF THE CERVIX [J].
BOICE, JD ;
ENGHOLM, G ;
KLEINERMAN, RA ;
BLETTNER, M ;
STOVALL, M ;
LISCO, H ;
MOLONEY, WC ;
AUSTIN, DF ;
BOSCH, A ;
COOKFAIR, DL ;
KREMENTZ, ET ;
LATOURETTE, HB ;
MERRILL, JA ;
PETERS, LJ ;
SCHULZ, MD ;
STORM, HH ;
BJORKHOLM, E ;
PETTERSSON, F ;
BELL, CMJ ;
COLEMAN, MP ;
FRASER, P ;
NEAL, FE ;
PRIOR, P ;
CHOI, NW ;
HISLOP, TG ;
KOCH, M ;
KREIGER, N ;
ROBB, D ;
ROBSON, D ;
THOMSON, DH ;
LOCHMULLER, H ;
VONFOURNIER, D ;
FRISCHKORN, R ;
KJORSTAD, KE ;
RIMPELA, A ;
PEJOVIC, MH ;
KIRN, VP ;
STANKUSOVA, H ;
BERRINO, F ;
SIGURDSSON, K ;
HUTCHISON, GB ;
MACMAHON, B .
RADIATION RESEARCH, 1988, 116 (01) :3-55
[3]   Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know [J].
Brenner, DJ ;
Doll, R ;
Goodhead, DT ;
Hall, EJ ;
Land, CE ;
Little, JB ;
Lubin, JH ;
Preston, DL ;
Preston, RJ ;
Puskin, JS ;
Ron, E ;
Sachs, RK ;
Samet, JM ;
Setlow, RB ;
Zaider, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :13761-13766
[4]   Normal organ radiation dosimetry and associated uncertainties in nuclear medicine, with emphasis on iodine-131 [J].
Brill, A. B. ;
Stabin, M. ;
Bouville, A. ;
Ron, E. .
RADIATION RESEARCH, 2006, 166 (01) :128-140
[5]   A comparison of radiation dose measured in CT dosimetry phantoms with calculations using EGS4 and voxel-based computational models [J].
Caon, M ;
Bibbo, G ;
Pattison, J .
PHYSICS IN MEDICINE AND BIOLOGY, 1997, 42 (01) :219-229
[6]  
Carr ZA, 2002, RADIAT RES, V157, P668, DOI 10.1667/0033-7587(2002)157[0668:MNARTF]2.0.CO
[7]  
2
[8]  
*CHIEF MED OFF DEP, 1996, STAT PUBL HLTH 1995
[9]  
CLARKE R, 2005, ANN ICRP, V34, P3
[10]  
*COMM EX RAD RISKS, 2004, REP PROD COMM UK